GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort NeuroScientific Corp (HKSE:02172) » Definitions » Loans Receivable

MicroPort NeuroScientific (HKSE:02172) Loans Receivable : HK$0.0 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is MicroPort NeuroScientific Loans Receivable?

MicroPort NeuroScientific's Loans Receivable for the quarter that ended in Jun. 2024 was HK$0.0 Mil.


MicroPort NeuroScientific Loans Receivable Historical Data

The historical data trend for MicroPort NeuroScientific's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort NeuroScientific Loans Receivable Chart

MicroPort NeuroScientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Loans Receivable
Get a 7-Day Free Trial - - - - -

MicroPort NeuroScientific Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

MicroPort NeuroScientific Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


MicroPort NeuroScientific Loans Receivable Related Terms

Thank you for viewing the detailed overview of MicroPort NeuroScientific's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort NeuroScientific Business Description

Traded in Other Exchanges
N/A
Address
No. 1661 Zhangdong Road, Pudong New Area, Shanghai, CHN
MicroPort NeuroScientific Corp formerly MicroPort NeuroTech Ltd is into the neuro-interventional medical device industry, dedicated to providing solutions for physicians and patients. The company boast a comprehensive portfolio of approved therapeutic products covering all of the three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke.
Executives
Microport Scientific Corporation
Hu Yibin
Biolink Biomedical Ltd. 2201 Interest of corporation controlled by you
Blossom Vision Limited 2201 Interest of corporation controlled by you
Lion Fish Limited 2201 Interest of corporation controlled by you
Suntera Corporate Trustees (hong Kong) Limited 2301 Trustee
Thriving Hope Limited 2201 Interest of corporation controlled by you
Biolink Fund Limited Partnership 2201 Interest of corporation controlled by you
Biolink Limited 2101 Beneficial owner
Microport Scientific Investment Ltd
Maxwell Maxcare Science Foundation Limited
We'tron Capital Limited

MicroPort NeuroScientific Headlines

No Headlines